Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL

PURPOSE: The 2018 American Urological Association guidelines on the Evaluation and Management of Testosterone Deficiency recommended that 300 ng/dL be used as the threshold for prescribing testosterone replacement therapy (TRT). However, it is not uncommon for men to present with signs and symptoms...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int Braz J Urol
Päätekijät: Madhusoodanan, Vinayak, Patel, Premal, Lima, Thiago Fernandes Negris, Gondokusumo, Jabez, Lo, Eric, Thirumavalavan, Nannan, Lipshultz, Larry I., Ramasamy, Ranjith
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Sociedade Brasileira de Urologia 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6844348/
https://ncbi.nlm.nih.gov/pubmed/31408289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0132
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia